Literature DB >> 24702729

Role of semen in modulating the female genital tract microenvironment--implications for HIV transmission.

Gustavo F Doncel1, Sharon Anderson, Irina Zalenskaya.   

Abstract

Semen deposition results in modulated immunity and an inflammatory response of the genital mucosa, which promotes conditions facilitating conception and pregnancy. These semen-induced alterations in the female reproductive tract can also have implications for the sexual transmission of viral infections such as HIV-1. Semen is not only a vector for HIV-1 but also a carrier for pro- and antiviral factors. Semen induces significant mucosal changes upregulating gene, and transcription factors leading to recruitment and activation of HIV target cells, stimulation of HIV replication and potentiation of Toll-like receptor responses. Although more research is needed to clearly elucidate the resulting collective effects of all these factors, semen modulation of the cervicovaginal microenvironment and immune system appears to lead, through multiple mechanisms, to mucosal changes facilitating viral entry and replication, likely resulting in enhanced susceptibility to acquire HIV-1 infection.
© 2014 The Authors. American Journal of Reproductive Immunology Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  HIV; semen; vaginal inflammation; vaginal innate immunity

Mesh:

Substances:

Year:  2014        PMID: 24702729     DOI: 10.1111/aji.12231

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  23 in total

1.  Concomitant Imbalances of Systemic and Mucosal Immunity Increase HIV Acquisition Risk.

Authors:  Charles S Morrison; Pai-Lien Chen; Hidemi Yamamoto; Xiaoming Gao; Tsungai Chipato; Sharon Anderson; Robert Barbieri; Robert Salata; Gustavo F Doncel; Raina N Fichorova
Journal:  J Acquir Immune Defic Syndr       Date:  2020-05-01       Impact factor: 3.731

2.  Modulation of the CCR5 Receptor/Ligand Axis by Seminal Plasma and the Utility of In Vitro versus In Vivo Models.

Authors:  Jennifer A Juno; Kathleen M Wragg; Anne B Kristensen; Wen Shi Lee; Kevin J Selva; Renee M van der Sluis; Anthony D Kelleher; Benjamin R Bavinton; Andrew E Grulich; Sharon R Lewin; Stephen J Kent; Matthew S Parsons
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

3.  Immune biomarkers and anti-HIV activity in the reproductive tract of sexually active and sexually inactive adolescent girls.

Authors:  Mimi Ghosh; Mariel Jais; Roshni Biswas; Jason Jarin; Jason Daniels; Christopher Joy; Monika Juzumaite; Vanessa Emmanuel; Veronica Gomez-Lobo
Journal:  Am J Reprod Immunol       Date:  2018-03-13       Impact factor: 3.886

4.  Epigallocatechin Gallate Inhibits Macaque SEVI-Mediated Enhancement of SIV or SHIV Infection.

Authors:  Run-Hong Zhou; Le Guo; Jin-Biao Liu; Hang Liu; Wei Hou; Tong-Cui Ma; Xu Wang; Jian-Guo Wu; Li Ye; Wen-Zhe Ho; Jie-Liang Li
Journal:  J Acquir Immune Defic Syndr       Date:  2017-06-01       Impact factor: 3.731

5.  Seminal vesicle fluid increases the efficacy of intravaginal HSV-2 vaccination.

Authors:  A Varese; F Remes Lenicov; M Gonzalez Prinz; A Paletta; G Ernst; C Maeto; A Merlotti; J Sabatte; S Símula; M P Holgado; E Dantas; J Geffner; A Ceballos
Journal:  Mucosal Immunol       Date:  2017-07-26       Impact factor: 7.313

Review 6.  Characteristics and quantities of HIV host cells in human genital tract secretions.

Authors:  Joseph A Politch; Jai Marathe; Deborah J Anderson
Journal:  J Infect Dis       Date:  2014-12-15       Impact factor: 5.226

Review 7.  Vaginal microbiota and sexually transmitted infections that may influence transmission of cell-associated HIV.

Authors:  Richard A Cone
Journal:  J Infect Dis       Date:  2014-12-15       Impact factor: 5.226

8.  Biomarkers of Cervical Inflammation and Immunity Associated with Cervical Shedding of HIV-1.

Authors:  Christine Mauck; Pai-Lien Chen; Charles S Morrison; Raina N Fichorova; Cynthia Kwok; Tsungai Chipato; Robert A Salata; Gustavo F Doncel
Journal:  AIDS Res Hum Retroviruses       Date:  2016-01-26       Impact factor: 2.205

9.  Broadly Neutralizing Anti-HIV Antibodies Prevent HIV Infection of Mucosal Tissue Ex Vivo.

Authors:  Yanille M Scott; Seo Young Park; Charlene S Dezzutti
Journal:  Antimicrob Agents Chemother       Date:  2015-11-23       Impact factor: 5.191

10.  A Longitudinal Assessment of Cervical Inflammation and Immunity Associated with HIV-1 Infection, Hormonal Contraception, and Pregnancy.

Authors:  Charles S Morrison; Raina Fichorova; Pai-Lien Chen; Cynthia Kwok; Jennifer Deese; Hidemi Yamamoto; Sharon Anderson; Tsungai Chipato; Robert Salata; Gustavo F Doncel
Journal:  AIDS Res Hum Retroviruses       Date:  2018-09-05       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.